Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
They have been BSing us all this while. They have been waiting on the phase 2 combo data all this while and timed other initiatives as well as manufactured some BS stories around that so retail doesn't give up or sue them for withholding this info. Wait until Feb-March 2024 for MAA submission to finally happen!
Without a big pharma involvement with 100s of millions in upfront cash, the share price will not move significantly in a meaningful way in 2024. There might be an occasional spike, if we are lucky, but shorts will play their game with this management at the helm. The big pharma not only brings big money but also lends credibility and experience….
Agreed. As long as these pumpers continue to defend the management and play the victim card by inundating social media platform on a daily basis, its prudent to assume they have limited to no confidence in building shareholder value anytime soon.
I think we will see significant upside in share price when these paid pumpers go quiet! Until then their job responsibility is to continue to build false and unreasonable expectations…
LOL, is that the word around the campfire these days? ;)
It’s unfortunate that your buddies including big pharma execs have been deceiving you for many years, and this seems to have clouded your understanding of this field. Or is that all part of the plan to rally retail? If so, it ain’t working just like LG’s BS over the years!
For that they will need to submit separate paperwork to NICE. NWBO team has show time and again they are unable to multitask or focus on more than one major milestone at a time. I bet they haven’t even started working on NICE paperwork yet. And once they finally do after MHRA submission hopefully in Q1 2024, they will unfortunately run into issues outside their control such as key folks going on vacation, consulting company acquired by an even larger outfit, etc.
Just like when all the pumpers including thermo were forecasting MHRA submission in the spring, i predicted nothing would happen this year. LP, LG, and DI has had a rich history of lies and deceit, and not so much on making timely progress or shareholder return!
Not sure why LP, LG are not able to convince investors to buy a boat load at 2-3 X our current valuation now, if 10X return was coming in 2024? You are making a case that LP, LG needs to go.
It wont be even 10% of that in Dec 2024 if this management is still running the show. I will guarantee that UK reimbursements will not be approved by Dec 2024 and neither will Flaskworks. Another lost year coming from a shareholder perspective! Pumpers will continue to build false expectations of the share price to string along retail.
I will make it easier for you to comprehend!
Scenario 1:
MHRA submission in April 2023.
Financing available at much higher share price in Q2 2023
MHRA approval by the end of year.
Pot of money becomes available at MHRA approval by end of 2023.
NICE application goes in Jan 2024.
Scenario 2:
Financing at depressed valuation throughout 2023.
MHRA submission in Jan 2024
NICE application in Jan 2024
MHRA approval in Q3 2024
Pot of money becomes available at MHRA approval in Q3 2024
Which makes sense and is advantageous?
Still you don't delay MHRA submission for months for NICE. They are 2 separate things.
I will tell you one more thing - Flaskwork will not be approved in 2024!
And they will not have NICE reimbursements approved in 2024 either. However, they will apply to NICE in 2024 without Flaskwork.
Stop with your BS!
Plus they are having no problem giving themselves 10s of millions of shares as true-up. Its all BS!
They are having their social media messengers fabricate these stories to make folks believe that it’s not the phase 2 combo data they have been waiting on but something or the other that’s resulting in this delay. Otherwise they could potentially get in legal trouble for withholding that info.
The reality in all likelihood is that they are just waiting for the phase 2 combo study to complete.
If we are lucky, the submission will happen in Feb-March time frame as soon as they have access to phase 2 combo data.
You don’t understand how these things work, do you? Or are you intentionally misleading people?
You don’t delay regulatory approvals for reimbursement to fall in place. You go ahead and make regulatory submissions anyway while you work behind the scenes on the reimbursement front. This way, you build excitement in the community as well as support for the share price and not finance at depressed valuation.
By the way, what about that pot of money UK allocated for such therapies that you continued to brag about until reimbursements came through? Change of narrative there as well? ;)
But NICE deflection anyway!
LOL, no one becomes big overnight. You have to consistently build value both for the company and the investors. We have been stuck in the reverse gear for well over a decade! ;) LP et al. has not been able to convince credible investors on the value of NWBO during these years. And it ain’t changing anytime soon. But you are welcome to defend the management!
Why inspired you to change your narrative around the delays in submission post MIA? You were quite vocal around the MIA approval phase that if the UK submission was delayed beyond a few weeks then they were purely on LP…..as they would have had more than enough time to apply immediately post MIA, which was already 30 months post data lock. Will you continue this strategy of flip flopping and defending the management at all cost in the future?
Bigger company jumps into reviewing these applications right away rather than focusing on integration, such BS!
I wonder what excuse you will give when there is no submission in December?
Yeah, he is a well known pumper. He makes all kinds of predictions to string retail along but it never comes through.
Sounds good. I wont post either if they submit before that.
Agreed. Although Hoffy predicted more than one submission in the summer! So did Dr. Zivic and others that consistently pump misleading timelines to keep retail engaged.
Curious if one of these guys (Danish Dude or Hoffy) lose their annual contract in 2024 because it’s becoming too obvious?
Flip,
First of all, you still have 3-4 weeks. Seems like you have already given up! ;) I am super busy with year end stuff at work coupled with business travels. Not sure if I missed some of your earlier posts on this.
Anyway, we spoke about the submission PR before the end of the year. Not that it matters because I don't believe they will submit in Jan either. It’s more likely they will PR another excuse or hype up another step that they resolved/completed in January rather than the final submission. I do this for living so I figured this was coming once they didn't submit within a couple of weeks of MIA.
As I said before, you are a reasonable poster. Your views are fairly balanced and you are not defending the management 24/7. So I have no problem with you staying active here even if you end up losing the bet.
My problem has always been with the paid pumpers such as Danish Dude, Hoffy and his multiple aliases, Biosect, as well as a few others that gaslight on a consistent basis. On the short side, everyone knows the intention of Ex, LC, IC, Hygro, etc. They do the opposite of Danish Dude, Hoffy and their colleagues.
Don't think any of that matters much at this point except that big, credible investors will always to be wary of the history with this management group and how they have treated shareholders in the past. These guys wont trust the NWBO team.
The important thing is UK submission.
If they do not file in December, the stock gets slammed.
And if they do not file in Jan 2024, it’s likely there is another lawsuit on this management.
You will not get a response to this. In all likelihood, the management decided to wait for ph 2 combo data a long time ago and intentionally withheld this material info from shareholders. This is why I believe they could potentially get in legal trouble in the coming months.
The story around delays with publisher and contractor is BS. It’s just a smoke screen!
Then she is quite gullible and/or has amnesia or lives in denial.
No one is saying NWBO will not apply in the UK in 2024. But all the lies they have spewed regarding timing and the excuses to string along retail is just nuts. I don't know how she cant see through that coupled with the history of this group. Something doesn't add up with these folks that continue to defend management at all cost.
No wonder a credible biotech investor who understands these processes will never trust this management. I am also certain there will be no combo partnership deal with big pharma in the first half of next year. It’s all a lie to keep investors on the hook to avoid a mass exit on the next pump! And when nothing happens by next summer in terms of upfront cash deal with big pharma combo partnership, the excuse from the social media army in Q3/Q4 next year will be its best to go alone. Big pharma doesn't bring anything and/or asked for too much….while dilutions continue and we still languish under a dollar!
Reimbursements in UK will likely not be worked out in 2024 either. And the revenue will be a couple of million dollar per quarter at best.
I agree. They use these pumpers to BS on their behalf. We have seen this pattern a lot over the last few years.
Senti’s defense (or shall I say pumping) will be exposed in Jan when nothing is submitted. Watch out for another excuse in the new year.
Not the first time they did that. There’s a rich history of that over the years! LG, DI, and LP are the lying crew.
On the other hand, I genuinely believe Dr. Bosch and Naveed Malik in the UK deserve much credit.
They have been lying! Hopefully someone will force them to give the name of the consultants and do some investigative work. ;)
Cant believe you trust DI, LG, and LP at their words any longer. How did LG’s comments go over the years - UK approval imminent from 3 years ago? And all the BS he has spewed on the biz booz show.
LP at a scientific conference 3 years ago - cant wait to share the data with the community?
DI’s working very very very hard and at the finish line comments for 3 years consistently?
I will be curious to see what excuse you give on behalf of the lying management crew in January.
Agreed. If it wasn't for the KOLs and brain tumor charities backing them I’d consider this business management group a scam!
Yup. I have been saying this since April when they didn’t submit within a couple of weeks of MIA. No regulatory applications take this long to submit! I have had a few class II and III neurology medical devices approved, some of which are just as complex as they what they are working on. The application paperwork is not that involved.
And we are not even talking about reimbursement part yet! ;)
He extracts the max compensation out of all the paid pumpers, purely based on the volume of posts across all social media and investor forums over the last couple of years. It’s more than a full time gig!
Ex and LC on the other side compete with him! ;)
BS. Its a deliberate strategy to wait until
Phase 2 combo data and they have been lying to us all this while. They will apply in mid to late Q1 once they get phase 2 combo data.
Watch out if any shareholders force LP to reveal some info about the consultant(s) and do minor investigative work. The management BS could get exposed!
It was expected. Let the blame game begin. It’s never management’s fault. Bunch of liars!
Also, this dude has had a history of speaking with DI and posting BS on behalf of the management on this board. He did that a lot during the 18-20 month quiet period after data lock….to keep shareholders on the hook!
It won’t be surprising if management gets sued in 2024.
He is embarrassed with his last pump. He will come back when it’s time to sell a few again! ;)
Yes, 10 years is just not enough to be considered a long term investor here. Opportunity cost is not important! ;)
Amen!
All these pumpers that say new technology applications take over 3 years to submit are BS artists. It just does not. And we are not even talking about reimbursements yet which is separate and is typically a more time consuming process for novel approaches and indications.
That will prove my theory that they have been waiting on combo data all this while. I have been saying that since April when they didn’t submit MAA within a couple of weeks of MIA.
Hopefully in Feb. I think the study completion is end of Jan.
I agree with your take except the below statement -
“Linda Powerless has no idea what she is doing.”
— She does. In fact, my theory is she has been doing this intentionally to string along retail until phase 2 combo data is available. Giving retail false hopes with timelines and making it sound like there is one more step before the final submission. They are also super careful about not being sued for intentionally withholding some info (where their plan was likely to wait until ph 2 data based on recommendation from their consultants and therefore they lined up those prerequisites accordingly rather than working in parallel or in advance or taking an alternate strategy). It’s been ongoing for 3 years and well orchestrated. No application takes this long whether you are a small or inexperienced team.
There will be no submission in December. The submission will hopefully happen in mid to late Q1 2024. They have just been waiting on combo data all this while and continued to BS shareholders over the last couple of years. They lied again in their October PR.
And he is supposedly a medical doctor, shameless! He dances to LP’s and LG’s tunes.
He is a well known pumper! He licks LG and LP a**, so he continues to receive inside info to trade on. He puts out fake timelines and has never been right. Do the opposite of what he says and you are more likely to make money. When there is no major cash influx at $2-3B valuation or combo deal with major pharma at UK application submission or acceptance, goal posts will move to UK approvals then reimbursements then FDA application then FDA approvals, and so on.
The dude is another know it all. Look at his history! $80M specials revenue in 2022. MHRA approvals in Q2 2023, and the list goes on!
It’s likely we will see a large dilution under a dollar in Q1/Q2 next year.
Nicely captured. This is what I have been pointing to. Helping their buddies sell into the pump so they can re-invest some of that money when the share price drop again to help them keep the lights on. Rinse and repeat.
Agreed. The only company in the world to PR 2 week out of office excuse with their consultant. The company is always looking to blame it on external parties!
It’s all a strategy to build a BS narrative. They will always remain a boutique outfit as no credible investor takes them seriously.
LOL, thats why they continue to reward themselves with true-up!